SCHEMBL2987285

SCHEMBL2987285

OCCCc1c(O)cc(O)cc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC28A3 Q9HAS3 2/20 0.57
NPC1 O15118 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KDM4E B2RXH2 3/20 0.38
BACE1 P56817 2/20 0.38
ALDH1A1 P00352 1/20 0.38
ALOX5 P09917 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
TYR P14679 3/20 0.36
ACHE P22303 1/20 0.35
IGF1R P08069 2/20 0.34
ALOX15 P16050 2/20 0.34
TNKS2 Q9H2K2 1/20 0.34
PKM P14618 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL110236 0.87 SLC28A3 (0.71) SLC28A3NPC1HPGDMAPK1HTT
SCHEMBL2979293 0.84 SLC28A3 (0.50) SLC28A3NPC1HPGDMAPK1HTT
SCHEMBL16046757 0.81 SLC28A3 (0.56) SLC28A3NPC1HPGDMAPK1HTT
SCHEMBL9743295 0.78 HTT (0.72) SLC28A3NPC1HPGDMAPK1HTT
SCHEMBL168062 0.76 HTT (0.63) SLC28A3NPC1HPGDMAPK1HTT
SCHEMBL5642306 0.76 TAAR1 (0.61) SLC28A3KDM4EBACE1ACHETNKS2
SCHEMBL2989121 0.75 KDM4E (0.41) SLC28A3NPC1HPGDMAPK1HTT
SCHEMBL19433103 0.75 PTGS2 (0.61) SLC28A3NPC1HPGDMAPK1HTT
SCHEMBL2982558 0.75 ALOX5 (0.41) SLC28A3MAPK1HTTKDM4EALDH1A1
SCHEMBL19433098 0.75 PTGS2 (0.61) SLC28A3NPC1HPGDMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7777073-B2 Topical delivery system for antiaging and skin whitening agents BIODERM RESEARCH (US) 2010-08-17 US disclosed
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents TYR, MMP17, MMP1 SLC28A3 1426/4885NPC1 1990/4885HPGD 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.